STEBFYBA Trademark

Trademark Overview


On Wednesday, December 12, 2018, a trademark application was filed for STEBFYBA with the United States Patent and Trademark Office. The USPTO has given the STEBFYBA trademark a serial number of 88226528. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2020. This trademark is owned by CHIESI FARMACEUTICI S.P.A.. The STEBFYBA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
stebfyba

General Information


Serial Number88226528
Word MarkSTEBFYBA
Filing DateWednesday, December 12, 2018
Status700 - REGISTERED
Status DateTuesday, February 18, 2020
Registration Number5987587
Registration DateTuesday, February 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
Translation of Words in MarkThe wording "STEBFYBA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHIESI FARMACEUTICI S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Party NameCHIESI FARMACEUTICI S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Party NameCHIESI FARMACEUTICI S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Trademark Events


Event DateEvent Description
Tuesday, February 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, January 14, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, December 10, 2019NOTICE OF ALLOWANCE CANCELLED
Monday, January 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 10, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 12, 2019ASSIGNED TO LIE
Thursday, March 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, March 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, March 11, 2019ASSIGNED TO EXAMINER
Friday, January 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 15, 2018NEW APPLICATION ENTERED IN TRAM